Form 4: Astrana Health Director David Schmidt Reports Acquisition and Disposal of Common Stock

Director David Schmidt reports acquiring 3,564 shares of Astrana Health common stock and disposing of 9,314 shares in a recent transaction.

Summary

• On August 13, 2024, David Schmidt, a director of Astrana Health, Inc., reported a transaction involving the company's common stock.
• Schmidt acquired 3,564 shares of common stock.
• Schmidt also disposed of 9,314 shares of common stock.
• Following the reported transaction, Schmidt beneficially owns 9,314 shares of Astrana Health, Inc.
• The acquired shares are restricted shares granted under the company's 2024 Equity Incentive Plan and will vest on the earlier of August 13, 2025, or the date of the company's 2025 annual meeting of stockholders.
• The reported holdings include 5,750 shares of restricted stock vesting on December 9, 2024, and 3,564 shares vesting on the earlier of August 13, 2025, or the 2025 annual meeting.
• Schmidt has a Power of Attorney naming Brandon Sim, Chandan Basho, John Vong, and Kathy Diep as attorneys-in-fact for SEC filings.

Sentiment

Score: 5

Explanation: The document presents a neutral view. While the acquisition of shares is positive, the disposal offsets some of that sentiment. The overall impact is likely to be minimal without further context.

Positives

• The acquisition of restricted shares by a director could be seen as a positive sign of confidence in the company's future.

Negatives

• The disposal of 9,314 shares by a director could be interpreted negatively by investors.

Risks

• The vesting of restricted shares is contingent on future events, such as continued service or meeting performance targets.
• Market conditions and company performance could impact the value of the shares.

Future Outlook

The vesting of the restricted shares is dependent on future events, indicating a long-term perspective.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key personnel.

Comparison to Industry Standards

• Comparing the vesting schedules and equity incentive plans to those of similar healthcare companies like Oak Street Health or Agilon Health could provide context on the competitiveness of Astrana Health's compensation structure.
• Analyzing insider trading activity relative to peers such as Alignment Healthcare or Cano Health could offer insights into the overall sentiment surrounding Astrana Health's stock.

Stakeholder Impact

• Shareholders may react to the reported transactions, potentially influencing the stock price.
• Employees may view the vesting of restricted shares as a positive incentive.

Next Steps

• Monitor future Form 4 filings by Astrana Health insiders for further insights into their trading activity.
• Track the vesting of the restricted shares and any related announcements.

Key Dates